Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer clinical trial (NCT01720836). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this vaccine compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer clinical trial (NCT01720836). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer clinical trial (NCT01720836). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer clinical trial (NCT01720836). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I respond well to the vaccine? Will there be follow-up treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer clinical trial (NCT01720836). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with the vaccine that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer clinical trial (NCT01720836). Contact the study team or your healthcare provider for specific answers.

What this study is about